Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Renat Badaev"'
Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure
Autor:
Daniil Zaytsev, Larisa Girshova, Vladimir Ivanov, Irina Budaeva, Dmitri Motorin, Renat Badaev, Julia Mirolubova, Evgeni Grobovenko, Tamara Chitanava, Ekaterina Zaykova, Julia Alexeeva, Andrey Zaritskey
Publikováno v:
Biology, Vol 9, Iss 2, p 28 (2020)
Objectives: To the best of our knowledge, data from Gemtuzumab ozogamicin in Acute Myeloid Leukemia (AML) patients with failure of organ functions and poor performance status are extremely lacking. Moreover, the fast recovery from organ failure, afte
Externí odkaz:
https://doaj.org/article/cbd4d77788ee49dbb2208dd30882ac7b
Autor:
Elza Lomaia, Tamara Chitanava, Yulia Vlasova, Dmitry Motorin, Sergey Voloshin, Darina Zammoeva, Renat Badaev, Yulia Matvienko, Elizaveta Efremova, Ekaterina Mileeva, Nadia Siordia, Olga Kulemina, Eugenia Sbityakova, Natalia Lazorko, Julia Alexeeva, Irina Martynkevich, Elena Karyagina, Natalia Ilyina, Nadezhda Medvedeva, Natalia Dorofeeva, Tatiana Shneider, Svetlana Stepanova, Vasily Shuvaev, Elena Morozova
Publikováno v:
Blood. 140:12192-12193
Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure
Autor:
Julia Mirolubova, Tamara Chitanava, Ekaterina Zaykova, Dmitri Motorin, Evgeni Grobovenko, Larisa Girshova, VV Ivanov, Julia Alexeeva, Irina Budaeva, Daniil Zaytsev, Renat Badaev, Andrey Zaritskey
Publikováno v:
Biology, Vol 9, Iss 2, p 28 (2020)
Biology
Biology
Objectives: To the best of our knowledge, data from Gemtuzumab ozogamicin in Acute Myeloid Leukemia (AML) patients with failure of organ functions and poor performance status are extremely lacking. Moreover, the fast recovery from organ failure, afte
Autor:
Yulia Mirolyubova, Daniil Zaytsev, Alexey Petrov, Tatiana Nikulina, Konstantin Bogdanov, Elena Tochenaya, Andrey Zaritskey, Renat Badaev, Dmitriy Motorin, Irina Budaeva, V. E. Ivanov, Alexina Shatilova, Yulia Alekseeva, Larisa Girshova, R.I. Vabishchevich
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S301
Context: Treatment of patients with relapsed and refractory AML who are not candidates for intensive treatment is an actual problem. Objective: Assess the efficacy of gemtuzumab ozogamicin (GO) in combination with azacitidine; assess factors impactin
Autor:
Irina Budaeva, Daniil Zaytsev, Alexina Shatilova, Elena Tochenaya, Alexey Petrov, Raisa Vabishchevich, Dmitriy Motorin, Renat Badaev, Vladimir Ivanov, Konstantin Bogdanov, Yulia Mirolyubova, Tatiana Nikulina, Yulia Alekseeva, Andrey Zaritskey, Larisa Girshova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S216
Autor:
Tatjana Nikulina, Julia Alexeeva, Daniil Zaytsev, Dmitry Motorin, Julia Mirolubova, Irina Budaeva, Renat Badaev, Konstantin Bogdanov, Andrey Zaritskey, Alexey Petukhov, Alexina Shatilova, Julia Rogovaia, Larisa Girshova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S199
Context Patients with NPM1 AML mutation are included in ELN favorable or intermediate genetic risk categories, although a proportion of these patients will relapse. Thus, it is necessary to identify negative prognostic factors for patientss with NPM1
Autor:
Georgiy G. Baratashvili, Tatyana Silina, Andrey Zaritskey, Dmitry Motorin, Diana Babenetskaya, Renat Badaev, Nataliya A. Ilyina, Yuliya A. Alexeeva, VV Ivanov
Publikováno v:
Cellular Therapy and Transplantation. 5:51-53
Autor:
Daniil Zaicev, Larisa Girshova, Tatjana Nikulina, Ekaterina Ovsiannikova, Konstantin Bogdanov, Julia Alexeeva, Irina Budaeva, Julia Mirolubova, Dmitrij Motorin, Andrey Zaritskey, Renat Badaev
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S204
Autor:
Julia Alexeeva, Natalia Ilina, Renat Badaev, Darina Zammoeva, Dmitriy Motorin, Andrey Zaritskey, Diana Babenetskaya
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S261